The c-MYC oncogene product influences many cellular processes, including growth, cell cycle progression, apoptosis, and differentiation (1) (2) (3) (4) . Deregulated expression of c-MYC and the related genes n-MYC and l-MYC have been observed in many naturally occurring human tumors (5) and may lead to reduced growth factor dependence, loss of genomic integrity, and transformation (6 -8) .
Myc proteins are bHLH-ZIP 1 transcription factors that bind to their cognate target genes in heterodimeric association with Max, another bHLH-ZIP protein (9, 10) . Recent evidence indicates that DNA binding by Myc-Max is associated with the recruitment of additional, non-bHLH-ZIP proteins, at least one of which is a histone acetylase (11) . Modification of condensed chromatin by histone acetylation appears to be an important step in controlling the access of additional transcription factors, which are otherwise sterically excluded (12) (13) (14) .
Max also participates in the negative control of transcription. Heterodimers between Max and at least four related bHLH-ZIP proteins (the MAD family, compete with Myc-Max heterodimers for DNA binding and actively repress transcription (15) (16) (17) . This function requires the assembly of a complex of proteins, distinct from that which associates with Myc-Max heterodimers, and includes mSin3A the mammalian ortholog of the yeast transcriptional repressor, and a histone deacetylase (14, 18 -22) . The ultimate balance between transcriptional activation and repression is determined, to a large extent, by the absolute levels of Myc and MAD proteins, all of which have relatively short half-lives and tend to be expressed oppositely from one another (23, 24) .
In addition to the above described heterodimeric interactions, the transcriptional activity of c-Myc is influenced by several non-bHLH-ZIP proteins that associate with its transactivation domain (TAD), which comprises the N-terminal ϳ150 amino acids of the protein (25, 26) . Two proteins, Bin-1 and TRRAP, have been the most intensely studied in this regard (27, 28) . Both interact with a subregion of the TAD, termed "Myc Box II" (MBII) that is highly conserved among all Myc oncoprotein members. MBII is required for c-Myc to properly regulate many of its target genes and to transform fibroblasts in vitro in association with activated ras oncogenes (29, 30) . Bin-1 appears to be a negative regulator of c-Myc transformation, whereas TRRAP appears to be a positive regulator (27, 28) . The mechanism by which Bin-1 represses transformation appears complex, but includes effects on the cell cycle and the promotion of apoptosis in response to c-Myc over-expression (26) . An important aspect of TRRAP1 function may involve its role as a docking site for a complex of proteins that includes one or more of the histone acetylases discussed above (11) .
We utilized a yeast two-hybrid approach to screen for proteins that interact with the c-Myc TAD. We describe one such protein, Pag, also known as MSP23 and peroxiredoxin-1. Pag is a 23-kDa protein whose cDNA was originally cloned from ras oncogene-transformed mammary epithelial cells (31) . It is upregulated by serum and by compounds that induce oxidative stress (32) . Pag has also been shown to interact with the Src homology-3 and kinase domains of c-Abl and to reverse the cytostatic effects of c-Abl (33) . In the current work, we show that Pag also interacts specifically with the MBII region of the c-Myc TAD both in vitro and in vivo. Pag overexpression promotes a marked increase in cell size and enhances apoptosis, thus mimicking two previously described c-Myc phenotypes. We also show that Pag and c-Myc are each able to protect cells from apoptosis induced by oxidative damage. In contrast, Pag inhibits anchorage-independent growth of c-Myc overexpressing fibroblasts and down-regulates some, but not all, c-Myc target genes. Our results identify Pag as an MBII-binding protein that can differentially regulate certain c-Myc-dependent functions. The ability of Pag to interact with and modulate the activities of both c-Myc and c-Abl strongly supports its candidacy as a tumor suppressor.
EXPERIMENTAL PROCEDURES
Yeast Two-hybrid Screening-Standard polymerase chain reactions (PCR) were used to amplify the indicated murine c-Myc sequences from previously described c-Myc expression vectors (30) . All PCR primers contained BamHI restriction sites in the 5Ј (forward)-primer and BglII sites in the 3Ј (reverse)-primer.
The initial "bait" plasmid consisted of an ADH1 promoter-driven fusion between codons 1 and 1067 of the human Sos guanyl nucleotide exchange factor and murine c-myc codons 2-147, which encode the TAD. Additional baits consisted of TAD mutants bearing deletions of MBI (codons 43-69), codons 70 -130, and MBII (codons 133-147), as well as a full-length wild-type c-myc (codons 2-439). The orientation, sequence, and reading frame of each clone were confirmed by DNA sequencing using a common pSos sequencing primer. pSos plasmids were introduced into the cdc25H yeast strain by the polyethylene glycol/ lithium acetate method, and transformants were selected on SD/Leu Ϫ ϩ glucose plates at 25°C. Successful transformation was confirmed by recovery of each input plasmid in the Escherichia coli XL-1 Blue strain. For cDNA library screening, the strain containing pSos-c-Myc (2-147) was expanded in liquid culture and transformed with a human spleen cDNA library unidirectionally cloned into the pMyr vector (Stratagene, La Jolla, CA). Approximately 2 ϫ 10 6 transformants were initially plated onto SD/Ura Ϫ leu Ϫ glucose plates and incubated for 2 to 3 days at 25°C. The barely visible colonies were then replica plates onto SD/ Ura Ϫ leu Ϫ galactose plates and incubated for an addition 5 to 7 days. Approximately 300 colonies Ͼ1 mm in size grew under these conditions. For DNA sequencing, 30 pMyr plasmids were recovered in XL-1 Blue cells (Stratagene) by selecting for chloramphenicol resistance.
Immunoblotting of yeast lysates was performed as described previously (34) using a monoclonal antibody against the Sos protein (Transduction Laboratories, Lexington, KY).
DNA Sequencing and Analysis-All pSos and pMyr plasmids were subjected to DNA sequencing on an ABI373 automated sequencer (Applied Biosystems, Foster City, CA). Sequencing primers were synthesized to regions ϳ150 bp upstream of the polylinker region of each plasmid. All pMyr clones derived from the spleen cDNA library were subjected to GenBank TM BLAST searches, which were used to establish the identity and reading frame of each insert sequence.
GST "Pull-down" Experiments-PCR was used to amplify the region between codons 2 and 219 of either wild-type c-Myc or a deletion MBII mutant. The common 5Ј PCR primer contained an engineered EcoRI site, and the 3Ј PCR primer contained a BamHI site. PCR products were digested with BamHI, blunt-ended with the Klenow fragment of DNA polymerase I, digested with EcoRI, and unidirectionally cloned into the EcoRI ϩ XhoI (blunt-ended) digested pGEX-4T vector (Amersham Biosciences). The orientation and reading frame of each insert was confirmed by DNA sequencing. In all cases, GST fusion proteins of the predicted sizes were induced and purified by glutathione-agarose affinity chromatography as described previously (35) . A Pag cDNA encoding the full-length protein was excised from the original pMyr yeast vector, recloned in pBluescript-SK (Stratagene), and used in a coupled T3 RNA polymerase in vitro transcription/translation reaction in a rabbit reticulocyte lysate system (Promega, Madison, WI). One-tenth of the reaction (5 l) was mixed with 1 g of each of the above GST proteins in 0.5 ml of NETN buffer (100 mM NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, and 0.5% Nonidet P-40 detergent (Sigma)). After 2 h of incubation at 4°C with continuous agitation, 20 l of NETN-washed glutathionecoupled agarose (Bio-Rad) was added, and mixing was continued for an additional 2 h at 4°C. Precipitates were collected by low speed centrifugation and washed five times in NETN buffer before being resuspended and boiled in SDS-PAGE buffer. Electrophoresis was performed on standard SDS-12% polyacrylamide gels followed by autoradiography of the dried gel (XAR film, Kodak, Rochester, NY).
Cell Culture, Soft Agar Colony Formation, and Tumorigenesis Assays-NIH3T3 and COS-7 cells were routinely cultured in Dulbecco's modified minimal essential medium (D-MEM, Invitrogen) supplemented with 2 mM glutamine, 100 units/ml penicillin G, 100 g/ml streptomycin, and 10% supplemented calf serum (all from Invitrogen). Rat1a fibroblasts were cultured identically except that 10% fetal bovine serum (FBS, Invitrogen) was used. 32D myeloid cells were cultured in RPMI 1640 medium (Invitrogen) supplemented with 10% FBS and 10% conditioned medium from the interleukin-3-producing WEHI-3B cell line. ST486 Burkitt's lymphoma cells were cultured in RPMI plus 10% FBS. All cultures were split at least twice weekly to maintain continuous logarithmic growth.
Soft agar colony assays for Rat1a transfectants were performed in 60-mm tissue culture plates by mixing 4 ϫ 10 3 cells in 2 ml of 0.35% molten agarose (Invitrogen) in D-MEM, 10% FBS. The mixture was plated on a 4-ml solidified layer of 0.7% agarose prepared in the same medium. The number and sizes of the resulting colonies were determined by microscopic visualization 12-14 days later.
For tumorigenesis assays, 3-4-week-old nude mice were obtained from Charles River Laboratories (Wilmington, MA). Five animals were used in each group. Each animal was inoculated subcutaneously with 10 7 Rat1a fibroblasts resuspended in 0.1 ml of D-MEM without serum. Tumor growth was monitored twice weekly.
Plasmids, Transfections, and Reporter Gene Assays-The mammalian expression vectors pSVL-neo, pSVL-puro, pSVL-neo-c-Myc, pSVLneo-c-Myc(delMBI), and pSVL-neo-c-Myc(delMBII) have been described previously (30) . Pag was expressed as a C-terminal Myc epitope-tagged (MT) protein either in the pSVL-puro vector or in the pCBF vector under the control of a cytomegalovirus early promoter (gift from M. Cole, Princeton University). Plasmid DNAs were purified on Qiagen columns (Qiagen, Chatsworth, CA) according to the directions of the supplier. Transient transfections using supercoiled DNAs were performed with LipofectAMINE reagent (Invitrogen). The indicated cell lines were plated at 8 ϫ 10 5 cells/dish in 100-mm tissue culture plates 1 day prior to transfection and were harvested 2 days after transfection. In addition to the indicated plasmids, each plate also received 1 g of pCMV␤gal (Clontech, La Jolla, CA). Lysates were assayed for ␤-galactosidase, luciferase, and CAT activities as previously described (36) . Stable transfections in NIH3T3 and Rat1a fibroblasts were performed using LipofectAMINE essentially as described above except that 2 days after the addition of DNA, cultures were split 1:5 and selected in either puromycin (1 g/ml, Sigma) or G-418 (750 g/ml absolute concentration, Invitrogen). After 10 -14 days, well isolated colonies were picked and expanded for further characterization. Stable transfections in 32D cells were performed by electroporation with linearized plasmid DNAs, selected 2 days later in the appropriate drug, and either pooled or cloned by limiting dilution in 96-well plates.
Co-immunoprecipitation Experiments-For co-immunoprecipitation from transiently transfected cells, 50% confluent 100-mm duplicate plates of COS-7 cells were each transfected with 5 g of the pSVLneoc-Myc plasmid, the pSVLneo-c-Myc(delMBI) plasmid, or the pSVL-neo c-Myc(delMBII) plasmid and 3 g of pSVLpuro-MT-Pag plasmid using LipofectAMINE. Control transfections consisted of the same amounts of each of the individual plasmids described above plus pSVLneo or pSVLpuro parental plasmids. 48 h later, cells were collected by scraping, washed three times in PBS, and resuspended in 0.32 M sucrose, 10 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 , and 1% Triton-X100 (Sigma) containing protease inhibitor mixture (Roche Molecular Biochemicals). After 10 min on ice, nuclei were concentrated by low speed centrifugation, washed twice, and resuspended in 1 ml of the same buffer. They were then disrupted on ice by a 30-s pulse with the microtip of a Branson sonifier at a setting of 7. The lysate was cleared by centrifugation at 10,000 ϫ g for 5 min followed by an additional round of clearing for 2 h at 4°C with 10 l of control IgG followed by 50 l of protein A-agarose (BioRad). After centrifugation, 10 l of rabbit anti-c-Myc antibody prepared against amino acids 1-262 of the human protein (sc-764, Santa Cruz Biotechnology) was added and incubated at room temperature for 2 h with constant agitation. Immune complexes were precipitated by the addition of 50 l of protein A-agarose for 2 h. After extensive washing, the complexes were resuspended in 50 l of SDS-PAGE lysing buffer, boiled, and resolved by SDS-12% PAGE. After semidry transfer to a PVDF membrane (Millipore, Bedford, NY), the membrane was blocked for 2 h with PBS, 0.1% Tween 20 (PBS-T) containing 5% dry milk. The membrane was then divided in two. The upper half was incubated with a 1:500 dilution of the above mentioned polyclonal anti-c-Myc antibody, and the lower portion was probed with a 1:500 dilution of the 9E10 anti-c-Myc epitope-tagged monoclonal antibody (sc-40, Santa Cruz). Both blots were incubated overnight at 4°C. After extensive washing in PBS-T, the first blot was incubated for 2 h at room temperature with a 1:500 dilution of horseradish peroxidase-conjugated goat-anti rabbit IgG (Santa Cruz), and the second blot was incubated identically with a 1:500 dilution of horseradish peroxidase-conjugated rabbit-anti mouse IgG. After washing in PBS-T, both blots were developed using an enhanced chemiluminescence kit (Renaissance Kit, PerkinElmer Life Sciences) according to the supplier's directions.
For co-immunoprecipitation of endogenous c-Myc and Pag proteins, 2 ϫ 10 7 cells from the ST486 Burkitt's lymphoma cell line were lysed and sonicated as described above. The supernatant was then cleared by the addition a 1:200 dilution of control goat serum for 2 h at room temperature followed by 50 l of staphylococcus A-agarose for an additional 2 h. The supernatant was then incubated with a 1:200 dilution of either control goat IgG or a goat anti-Pag IgG (sc-7380, Santa Cruz) for 2 h at room temperature followed by the addition of 50 l of protein-A agarose. The precipitates were washed three times with 1 ml of lysis buffer, divided into two equal fractions, boiled in running buffer, and resolved by 10% SDS-PAGE. After Western transfer, one of the duplicate PVDF membranes was probed with a 1:500 dilution of the 9E10 anti-c-Myc monoclonal antibody and the second membrane was probed with a control antibody. Both blots were then developed by chemiluminescence.
Protein Content and Protein Synthetic Rates-3T3-neo or 3T3-Pag cell lines were grown in 100-mm plates to ϳ80% confluency. To determine the total protein content, triplicate cultures were harvested individually by scraping, and the total number of cells was determined by manual counting using a hemacytometer. Equivalent numbers of cells were then pelleted by low speed centrifugation, lysed, and the protein content determined using BCA reagent (Pierce). The rate of protein synthesis was determined by washing an equivalent set of triplicate plates three times in PBS followed by the addition of 3 ml of cysteine ϩ methionine-free D-MEM (ICN Biomedicals, Costa Mesa, CA). After a 30-min incubation at 37°C, 35 S-labeled cysteine ϩ methionine (Easytag protein labeling mix; specific activity, 1175 Ci/mmol, PerkinElmer Life Sciences) was added to a final concentration of 200 Ci/ml for 1 h. The cells were then harvested by scraping, washed three times in PBS, and lysed for 30 min in 1 ml of 10 mM Tris, pH 8.0, 1% SDS, plus protease inhibitor mixture. 10 l of each lysate ϩ 20 g of carrier bovine serum albumin was precipitated by the addition of 1 ml of ice-cold 10% trichloroacetic acid. The precipitates were collected on 25-mm GF/A glass fiber papers (Whatman), washed exhaustively with cold 10% trichloroacetic acid, dried, and subjected to scintillation counting.
Flow Cytometry-Flow cytometric analysis of propidium iodidestained nuclei was performed on a BD Pharmingen FACSTAR fluorescence-activated cell sorter (8). 2 ϫ 10 4 cells were analyzed for each assay. Quantitation was performed using single histogram statistics.
RESULTS

Identification of Pag as an MBII-interacting Protein-To
identify proteins that interact with the c-Myc TAD, we conducted a yeast two-hybrid screen using the TAD (amino acids 2-147) as the bait. Because this region is highly self-transactivating in conventional two-hybrid assays, 2 we utilized the CytoTrap TM system (Stratagene) in which interaction between bait and target proteins reconstitutes the Ras signaling pathway in Saccharomyces cerevisiae. A yeast strain expressing the c-Myc TAD in the pSos vector was transformed with a pMyr human spleen cDNA expression library, and 2 ϫ 10 6 colonies were screened for growth at 37°C. 30 pMyr plasmids were recovered for DNA sequencing, which showed that six encoded in-frame fusions with Pag. Of these, three initiated at different positions within the 5Ј-untranslated region or within five codons of the Pag translational start site. Five other pMyr isolates contained in-frame fusions with a cDNA encoding the previously described c-Myc-interacting protein, MM-1 (37) .
We initially verified the specificity of the observed interaction between c-Myc and Pag in yeast. One of the full-length pMyr-Pag plasmids was co-expressed with the original pSos-cMyc (2-147) TAD vector, pSos encoding a fusion with fulllength c-Myc (pSos-c-Myc-(2-439)), or a series of pSos-c-Myc fusions containing deletions within the c-Myc TAD (30) . These deletions included Myc Box I (MBI, codons 43-69), codons 70 -130, and MBII (codons 133-147). Two additional yeast strains served as independent positive and negative controls for growth at 37°C. The first contained pSos and pMyr plasmids, each of which expressed the full-length MafB protein.
The second contained a pSos-collagenase IV fusion protein and a pMyr-lamin C fusion protein. After selection of Leu ϩ Ura prototrophs at 25°C, several colonies of each strain were replated and grown at 37°C. As seen in Fig. 1 , yeast containing either the original pSos-c-Myc (2-147) bait or the full-length c-Myc protein readily grew at 37°C in the presence of coexpressed Pag (lines 5 and 6), thus confirming the original finding as well as indicating that interaction between c-Myc and Pag occurred with the full-length forms of both proteins. Deletions of either MBI or of the region between MBI and MBII (amino acids 70 -130) still permitted strong interaction with Pag (lines 7 and 8). However, deletion of MBII abolished the interaction (line 9). As expected, growth at 37°C was seen with yeast harboring the MafB fusion proteins (line 2), whereas no growth was seen in yeast expressing only a single fusion protein (lines 3 and 4) or the pSos-collagenase and pMyr-lamin C combination (line 1). Finally, growth at 37°C was seen only when the yeast were propagated on galactose-containing plates, thus verifying that both fusion proteins need to be expressed.
To confirm the validity of the observed interactions, several of the above yeast strains were propagated in liquid culture and examined by immunoblotting (34) using a monoclonal antibody directed against Sos. As seen in Fig. 1C , each of the yeast strains expressed a pSos fusion protein of the predicted size. These results indicated that the failure of Pag to interact with the MBII-deleted form of c-Myc was not because of lack of expression of the latter protein. In other experiments, we asked whether endogenous c-Myc and Pag could be co-immunoprecipitated. Preliminary studies determined that the ST486 Burkitt's lymphoma cell line expressed high levels of both proteins (not shown). Therefore, a lysate from this cell line was incubated with an anti-pag antibody or with an equivalent amount of a control antibody. Following the addition of protein A-agarose, the precipitates were divided in two, and each was resolved by SDS-PAGE and blotted to a PVDF membrane. One of the blots was then incubated with the 9E10 anti-c-Myc monoclonal antibody, and the second blot was incubated with a control antibody. As seen in Fig. 3B , c-Myc was detected only in lysates that had first been immunoprecipitated with the anti-Pag antibody followed by blotting with the anti-c-Myc antibody. Together with the results shown in Fig. 3A , these experiments established that c-Myc and Pag associate either when overexpressed under transient transfection conditions or in their endogenous states.
Increased Size of Pag-overexpressing Cells-To determine the effects of Pag on various cellular properties, we established cell lines that stably expressed the epitope-tagged Pag protein described above. We initially chose 32D myeloid cells and NIH3T3 fibroblasts, as numerous studies of Myc network proteins have been performed in these or closely related cells. As seen in Fig. 4 , high levels of Pag expression were detected in two 32D clones, in the pooled population of 32D cells (32D-Pag cells), and in three NIH3T3 clones (3T3-Pag cells). The epitopetagged protein was not detected in either cell line transfected with the empty pSVLneo parental vector alone. In other experiments (not shown), we have determined that Pag transcripts and protein driven by this vector in these cells are expressed at levels ϳ3-5 times higher than endogenous Pag levels but still within the range of the endogenous levels seen in liver, kidney, and some cell lines.
Under conditions in which the obligate hematopoietic cytokine interleukin-3 was in excess, 32D-Pag cells grew at rates comparable with those of 32D-neo controls and reached similar saturation densities (Fig. 5A) . In contrast, 3T3-Pag cells initially grew at the same rate as 3T3-neo controls but ceased growing much earlier and at lower saturation densities than 3T3-neo cells.
Morphologic examination showed striking differences between Pag-expressing and control cell lines (Fig. 5B ). In the case of the 32D-Pag population, large cells, which were otherwise quite similar in appearance to 32D-neo cells, were observed frequently. 3T3-Pag cells also appeared larger than controls and were much less spindle-shaped. Determination of cell size by flow cytometry confirmed these differences (Fig. 5C ). In addition, both The larger size of 32D-Pag and 3T3-Pag cells might have been the result of swelling, due, for example, to altered permeability or to an actual increase in cell mass, as has been described for certain c-Myc-over-expressing primary cells (38, 39) . To distinguish between these alternatives, we measured the protein content and the rate of protein synthesis in 3T3-Pag and 3T3-neo cells. As seen in Fig. 6 , 3T3-Pag cells contained ϳ40% more protein on a per cell basis and also incorporated more radiolabeled amino acids. Therefore, the increased size of Pag-expressing cells is due to an overall increase in cell mass.
Pag Inhibits c-Myc-mediated Anchorage-independent Colony Formation and Tumorigenesis-A notable feature of c-Myc is its ability to confer anchorage-independent growth to certain fibroblast cell lines, which can then grow as nonmetastatic tumors in nude mice (29) . We therefore asked whether the concurrent expression of Pag altered these attributes. We derived cell lines of Rat1a fibroblasts that expressed c-Myc (Rat1a-c-Mycϩpuro), Pag (Rat1a-neoϩPag), or a combination of c-Myc and Pag (Rat1a-c-MycϩPag). A control cell line (Rat1a-neoϩpuro) was also established from cells transfected with each of the empty pSVL parental vectors (Fig. 7A) . Several independently derived clones of each were tested for their abilities to form colonies in soft agar. As seen in Fig. 7B , the colony forming ability of Rat1a-c-MycϩPag was reduced by half compared with Rat1a-c-Mycϩpuro cells. Much more striking, however, was the marked reduction in overall colony size. Whereas only about 40% of the Rat1a-c-Mycϩpuro colonies were Ͻ100 M in diameter, nearly 80% of Rat1a-c-MycϩPag colonies were of this smaller size (Fig. 7C) . Thus, the concurrent expression of Pag attenuates both the average number and size of Rat1a colonies that grow in soft agar as a result of c-Myc overexpression.
To correlate the reduction in soft agar colony size and number observed in the foregoing experiments with in vivo tumorigenic capacity, each of the cell lines was tested for its tumorigenic ability. As seen in Fig. 7D , Rat1a-c-Mycϩpuro cells formed rapidly growing tumors in five of five nude mice. In contrast all five animals inoculated with Rat1a-c-MycϩPag cells showed a marked decrease in the size of their tumors. In addition, those tumors that did develop did so much more slowly than tumors originating from Rat1a-c-Myc cells.
Pag Acts Independently but Also Cooperates with c-Myc to Promote Apoptosis-Another well known property of c-Myc is its ability to promote apoptosis following withdrawal of growth factors (40, 41) . To assess the role of Pag on this process, several of the Rat1a clones described in Fig. 7 were grown to ϳ80% confluence and deprived of serum, and the number of viable cells was determined over the course of the subsequent 4 days. As seen in Fig. 8 , control Rat1a-neoϩpuro cells were relatively resistant to serum deprivation, with Ͼ70% surviving until the end of the experiment. As expected, Rat1a-cMycϩpuro cells showed an accelerated rate of cellular demise. Rat1a-neoϩPag cells also showed a greater rate of apoptosis, although, in general, this was not as pronounced as that observed with Ra1a-c-Mycϩpuro cells. Compared with either Rat1a-c-Mycϩpuro or Rat1a-neoϩPag cells alone, Rat1a-cMycϩPag cells showed a modest increase in the rate of cell death that was most apparent 2-3 days after serum withdrawal. In all cases, cell death was determined to be apoptotic by both TUNEL staining (42) and flow cytometric analysis of subdiploid DNA content (not shown). This is consistent with previous findings that the accelerated cell death of serumdeprived c-Myc-overexpressing fibroblasts is apoptotic in nature (41, 42) . From these experiments, we conclude that Pag itself is nearly as efficient as c-Myc in promoting apoptosis in Rat1a fibroblasts and that the two proteins cooperate, albeit weakly.
Pag and c-Myc Both Protect against Cell Death Mediated by
Oxidative Stress-Previous studies have shown that c-Myc accelerates apoptotic cell death in response to a variety of stimuli (40 -43) . However, the mechanisms through which this is accomplished may differ depending on the nature of the insult (Ref. 43 and references therein). In apparent contrast, Pag, a member of the peroxiredoxin family, is up-regulated in response to oxidative stress, thus suggesting that it plays a role is protecting cells against the cell death mediated by reactive oxygen species (32) . Surprisingly, this hypothesis has not been directly tested in cells exposed to an oxidative environment.
To study the effects of c-Myc and Pag on the cellular response to oxidative stress, the previously described 32D-c-Myc cells 32D-neo cell lines (30) were each transfected with either the pSVLpuro-MT-Pag vector or the pSVLpuro parental control vector. Stable transfectants were then pooled, and the expression of epitope-tagged Pag was confirmed (Fig. 9A) . We then monitored the survival of these cell lines following a single exposure to 80 M hydrogen peroxide (H 2 O 2 ). As seen in Fig. 9 , B and C, control 32Dneoϩpuro cells were quite sensitive to (44) . Subsequently, a number of naturally occurring E-box-containing c-Myc target genes have been characterized (45) . Using cDNA microarrays, we have identified a large number of putative c-Myc target genes in 32D myeloid cells and shown that the expression of most of them is MBII-dependent (30) . To determine whether Pag affects the expression of c-Myc target genes, we initially relied upon transient transfection assays in NIH3T3 cells. We utilized a previously described luciferase reporter under the control of a neutral adenovirus E1b promoter containing three repeats of an E-box motif (36) . In a second set of transient transfections, we utilized a CAT reporter juxtaposed to the natural promoter and first intron of the c-Myc-responsive hu- man ornithine decarboxylase gene (46) . As seen in Fig. 10, A and B, and as described previously (35, 36) , c-Myc activated both promoters 2-4-fold, whereas the co-expression of Pag resulted in a dose-dependent abrogation of transcriptional activation.
We next utilized some of the 32D cell lines described above to determine whether c-Myc target genes (30) were modulated by concurrent Pag expression. Total RNAs were therefore extracted from each of the four cell lines shown in Fig. 9A and used for Northern blots. These were then hybridized with four cDNA probes representing genes previously demonstrated to be induced by c-Myc and to require an intact MBII domain (30) . As seen in Fig. 10C , none of the genes was expressed in either control 32D-neoϩpuro cells or in 32D-neoϩPag cells. Strong up-regulation of all four genes was seen in 32D-c-Mycϩpuro cells, confirming our previous observations (30) . In three of the four cases, strong down-regulation of target transcripts was seen in 32D-c-MycϩPag cells. The exception was seen in the case of EST 444412. From these and the foregoing experiments, we conclude that Pag modulates some but not all c-Myc target genes.
DISCUSSION
Pag is a highly conserved protein that is up-regulated in ras oncogene-transformed primary mammary epithelial cells (31) . The presumed murine ortholog, MSP23, was cloned from peritoneal macrophages subjected to oxidative stress (47) . Subsequent work has demonstrated that, like c-Myc, Pag is induced in serum-stimulated quiescent cells and is down-regulated during HL-60 myeloid cell differentiation (31) . Pag is a member of a large family of stress-related proteins termed peroxiredoxins and is induced by a variety of compounds that mediate oxidative damage (32) . A closely related protein, MER5/Aop1, is induced in differentiating Friend murine erythroleukemia cells The indicated Rat1a cell lines were grown to ϳ80% confluency and then deprived of serum. Viable cell counts were performed daily using trypan blue exclusion and were confirmed using TUNEL assays (42) . The points shown represent the average of triplicate experiments Ϯ 1 S.E. and may actually serve to promote this process (48) . These observations suggest that Pag and its relatives are involved in the regulation of proliferation, differentiation, and transformation, all of which are also regulated by c-Myc. However, a direct role for Pag in any of the above functions has not been firmly established. Because c-Myc is a nuclear protein (49) and because Pag localizes to both the nucleus and the cytoplasm (33), 2 it seems likely that the c-Myc-Pag interaction occurs in the former cellular compartment. Our observation that green fluorescent protein-tagged c-Myc remains nuclear when co-expressed with excess Pag (not shown) is consistent with this idea, as is the finding that Pag overexpression still allows c-Myc to regulate the expression of EST 444412 (Fig. 10C) .
Pag also interacts with the Src homology-3 and kinase domains of the c-Abl oncoprotein and inhibits the cell cycle arrest associated with c-Abl overexpression (33) . Based on this property, as well as the finding that it maps to 1p34.1 (50), a region commonly deleted in certain leukemias, breast cancers, and neuroblastomas (51), Pag has been proposed to be a tumor suppressor (33, 52) . This is supported by our current finding that Pag inhibits c-Myc-mediated soft agar colony formation and tumorigenesis (Fig. 7, B-D) as well as by a previous observation that decreased Pag levels in oral cancer are associated with increased tumor size, lymph node metastasis, and lack of differentiation (52) . The fact that transformation by v-Abl and Bcr-Abl oncoproteins requires the concurrent expression of cMyc (53) lends further support to the notion of a functional triad involving c-Myc, c-Abl, and Pag.
Despite its ability to suppress the activities of two oncoproteins, both of which can modulate cell cycle progression, Pag itself exerts no obvious effect on this process. Thus, the actual role for Pag in regulation of the cell cycle may involve more subtle aspects of its interactions with c-Myc and c-Abl, perhaps during periods of oxidative stress or differentiation when Pag may normally be expressed at elevated levels and c-Myc levels are often declining (1, 32, 54) .
The ability of Pag to attenuate colony formation and tumorigenesis by c-Myc-over-expressing fibroblasts (Fig. 7) may be related to its effects on gene expression (Fig. 10) . Both of these properties are highly dependent upon the presence of an intact MBII domain of c-Myc (12, 30) . The direct MBII-dependent physical association between c-Myc and Pag both in vitro and in vivo (Figs. 1-3 ) strongly suggests that Pag affects these biological activities through its interaction with MBII much as does the putative tumor suppressor, Bin-1 (27) . On the other hand, direct interaction, or even cooperation, between Pag and c-Myc does not seem necessary for the promotion of apoptosis by the former protein. This observation is based on the finding that Pag induces apoptosis in serum starved fibroblasts, which typically do not express c-Myc. Indeed, the enforced co-expression of c-Myc and Pag leads to only a modest increase in apoptosis over that seen with either gene alone (Fig. 8) .
In contrast to the above examples of c-Myc dependent and independent functions for Pag, the role for endogenous c-Myc in promoting cell growth in response to Pag over-expression is less clear. Recent reports have indicated that c-Myc increases cell mass in certain primary cell types without substantially affecting proliferation (38, 39) . This is precisely the phenotype we have observed with Pag over-expression in two established cell lines (Figs. 5 and 6 ). Although it is tempting to suggest that this reflects enhanced endogenous c-Myc function as a result of its interaction with Pag, we have not demonstrated this directly and the actual basis for the increased size of Pag overexpressing cells remains to be established.
3T3-Pag cells attain a lower saturation density than 3T3-neo cells (Fig. 5A) . We believe this is largely a result of the increased cell surface area occupied by the former cells and thus their more rapid attainment of a contact inhibited state (Fig,  5B) . It is to be expected that these cells would require a larger surface area given their overall larger size (Fig. 5C ). In contrast, 32D-Pag and 32D-neo cells reach similar saturation densities. This likely reflects their reduced sensitivity to the growth constraints imposed by cell-cell contact, despite their size differences.
The effect of Pag on certain c-Myc-regulated biological functions occurs in the face of a significant loss of regulation of certain c-Myc target genes (Fig. 10) . We have previously shown that the presence of MBII is required for the proper regulation of most c-Myc targets (30) . Thus, the loss of this regulation could reflect the simple masking of MBII by bound Pag. On the other hand, Pag does not affect c-Myc-mediated regulation of EST 444412, which is highly MBII-dependent (30) . The loss of transcriptional activity by c-Myc in the face of its retention of at least some activities is reminiscent of c-MycS, a truncated, naturally occurring form of c-Myc lacking the first 100 amino acids of the TAD (55). c-MycS is able to promote proliferation, apoptosis, and anchorage-independent colony formation, and yet it lacks transcriptional activation potential and tumorigenic activity (56) .
Finally, our studies with Pag have shown that its stable over-expression is associated with protection against H 2 O 2 -mediated apoptotic cell death. This finding was not unexpected, given that Pag is a member of the large peroxiredoxin family (57, 58) . Much more surprising, however, was the observation that c-Myc itself could exert a similar degree of protection. Previous studies have demonstrated that c-Myc sensitizes cells to a number of heterogeneous apoptotic stimuli including serum and cytokine withdrawal, chemotherapeutic drugs, and ␥-interferon (30, 40 -43) . The finding that c-Myc exerts an anti-apoptotic effect in response to reactive oxygen species provides further evidence for its functional relatedness to Pag. Perhaps more importantly, it suggests that, by altering the apoptotic threshold to H 2 O 2 , c-Myc might modify the effects of various growth factors and cytokines, many of which have been shown to generate H 2 O 2 and other reactive oxygen species (reviewed in Ref. 59 ). In some cases, these have been shown to influence proliferation, growth, apoptosis, transformation, and differentiation, all of which are significantly influenced by cMyc (1, 3, 4, 6, 59) .
In summary, we have demonstrated that Pag, previously described as participating in the oxidative stress response and in negatively regulating the tyrosine kinase activity and cytostatic properties of c-Abl, also interacts specifically with the MBII domain of c-Myc. The consequences of this interaction include effects on cellular growth, transformation, apoptosis, response to oxidative stress, and c-Myc target gene transcription. The regulation by Pag of both c-Myc and c-Abl, its intriguing chromosomal location, and its reduced expression in certain human cancers support the idea that Pag functions as a tumor suppressor. It will be of interest to determine the relationship between Pag and other previously described MBII-binding proteins such as Bin-1 and TRRAP. (35, 36) . Each plate was transfected with the indicated amounts of each plasmid, harvested 2 days later, and assayed for luciferase after adjusting for differences in ␤-galactosidase activities The results shown are the average of 3-4 experiments Ϯ 1 S.E. B, transient transfections in NIH3T3 cells using the pODC-CAT reporter. Transfections were performed as described in A. After 2 days, cells were lysed and assayed for CAT after adjusting for differences in ␤-galactosidase activity. The results shown are the average of three independent experiments Ϯ 1 S.E. C, c-Myc target gene expression in 32D cells lines. 5 g of total RNA from each of the 32D cell lines shown in Fig. 9A was subjected to Northern blotting and hybridized with 32 P-labeled cDNA probes for the indicated transcripts (30) . In the bottom panel, one of the blots was stripped and reprobed with a labeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe as a control for RNA loading.
